| 1 | [SID121087] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice [AID206, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice | | AID | 206 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID121087] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID328, Type: other] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 328 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID565907] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 565907 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice [AID212, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 212 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice [AID230, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice | | AID | 230 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphoma 8 (intraperitoneal) in CD2F1 (CDF1) mice [AID244, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lymphoma 8 (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 244 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice [AID264, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice | | AID | 264 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intravenous) in B6C3F1 mice [AID276, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intravenous) in B6C3F1 mice | | AID | 276 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID73655] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 73655 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID121087] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice [AID192, Type: other] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 192 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID121087] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice [AID200, Type: other] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice | | AID | 200 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID121087] | Inconclusive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice [AID296, Type: other] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 121087 | | CID | 236 | | Outcome | Inconclusive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice | | AID | 296 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|